Ignite Creation Date:
2025-12-24 @ 1:33 PM
Ignite Modification Date:
2026-04-17 @ 7:28 PM
Study NCT ID:
NCT01055795
Status:
COMPLETED
Last Update Posted:
2012-12-24
First Post:
2010-01-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Study of Bevacizumab, Everolimus and LBH589 (BEL) for Advanced Solid Tumors
Sponsor:
Herbert Hurwitz
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Pro00020190
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None